Physical examination, diagnostic tests, laboratory testsPersonal history
Physical examination, diagnostic tests, laboratory tests: Physical examination, diagnostic tests (e.g. lung function test, echocardiography, audiometry), and laboratory tests (e.g. kidney parameter, hormonal levels) depend on examined organ system.
Personal history: Personal history on diagnosis, treatment, and socioeconomic factors
Study summary
The Young Survivors at Kantonsspital Aarau project assesses the prevalence and severity of late effects in survivors of childhood and adolescent cancer according to the modified CTCAE criteria prospectively. The clinical data are generated during regular follow-up care visits, the collection starts directly after completion of treatment and is longitudinally.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
Group A:
Children and adolescents who:
* have been treated for cancer in the Division of Oncology-Hematology, Department of Pediatrics, at the Kantonsspital Aarau,
* have been diagnosed at age 0-18 years,
* are still in regular follow-up care at the Kantonsspital Aarau,
* have finished cancer treatment and entered follow-up care, and
* signed informed consent
Group B:
Adolescents and adults who:
* fulfill the same inclusion criteria as Group A
* are not in regular follow-up care anymore
Exclusion Criteria:
Childhood Cancer Survivors who:
* are in a palliative situation or
* have not given consent for further use of medical data
Primary outcome measure(s)
Test results to assess organ-specific late effects (example of cardiac health) — at recruitment or 2016 onwards, whichever comes first Number of survivors with heart valve disorder, hypertension, left ventricular systolic dysfunction when at risk for cardiac late effects
Trial sites (1)
Facility
City
Region
Status
Division of Oncology - Hematology, Department of Pediatrics, Kantonsspital Aarau
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
